Ronald Blue Trust, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 67 shares of ARWR stock, worth $1,434. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67
Previous 44
52.27%
Holding current value
$1,434
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
91.1MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$336 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$262 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$190 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$136 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$105 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.27B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...